Growth Metrics

Cullinan Therapeutics (CGEM) Other Gross PP&E Adjustments (2020 - 2023)

Cullinan Therapeutics (CGEM) has 4 years of Other Gross PP&E Adjustments data on record, last reported at -$2.9 million in Q3 2023.

  • For Q3 2023, Other Gross PP&E Adjustments rose 34.94% year-over-year to -$2.9 million; the TTM value through Sep 2023 reached -$2.9 million, up 34.94%, while the annual FY2022 figure was -$2.8 million, 1012.94% down from the prior year.
  • Other Gross PP&E Adjustments reached -$2.9 million in Q3 2023 per CGEM's latest filing, up from -$3.5 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $309000.0 in Q4 2020 and bottomed at -$4.5 million in Q3 2022.
  • Average Other Gross PP&E Adjustments over 4 years is -$2.1 million, with a median of -$2.8 million recorded in 2022.
  • Peak YoY movement for Other Gross PP&E Adjustments: tumbled 1012.94% in 2022, then skyrocketed 34.94% in 2023.
  • A 4-year view of Other Gross PP&E Adjustments shows it stood at $309000.0 in 2020, then changed by 0.0% to $309000.0 in 2021, then crashed by 1012.94% to -$2.8 million in 2022, then fell by 3.69% to -$2.9 million in 2023.
  • Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$2.9 million in Q3 2023, -$3.5 million in Q2 2023, and -$3.8 million in Q1 2023.